Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 1;58(7):888.
doi: 10.3390/medicina58070888.

Moisturizer in Patients with Inflammatory Skin Diseases

Affiliations
Review

Moisturizer in Patients with Inflammatory Skin Diseases

Seok-Young Kang et al. Medicina (Kaunas). .

Abstract

As interest in skin increases, the cosmetic market is also growing. It is difficult to choose between the numerous types of basic cosmetics on the market. This article aims to provide advice and guidance on which products to recommend according to a patient's skin condition. Appropriate application of a moisturizer attempts not only to improve the dryness, but also improve the skin's natural barrier function to protect the skin from internal and external irritants to keep the skin healthy. Moisturizers consist of various ingredients, including occlusive agents, emollients, humectants, lipid mixture, emulsifiers, and preservatives. Pathophysiology of dry skin is also discussed to provide readers with the background they need to choose the right moisturizer for themselves. As moisturizers play an important role as adjuvant in the treatment of common skin diseases, such as atopic dermatitis, contact dermatitis, psoriasis, acne and rosacea, which type of moisturizer is appropriate for each disease was also dealt with. Basic cosmetics, especially moisturizers, should be recommended in consideration of the ingredients, effectiveness and safety of each product, and the skin condition of each patient.

Keywords: cosmeceutical; cosmetics; moisturizer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kligman A. The future of cosmeceuticals: An interview with Albert Kligman, MD, Ph.D. Interview by Zoe Diana Draelos. Pt 2Dermatol. Surg. 2005;31:8890–8891. - PubMed
    1. Assali M., Zaid A.N. Features, applications, and sustainability of lipid nanoparticles in cosmeceuticals. Saudi Pharm. J. 2022;30:53–65. doi: 10.1016/j.jsps.2021.12.018. - DOI - PMC - PubMed
    1. Pandey A., Jatana G.K., Sonthalia S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Cosmeceuticals. - PubMed
    1. Shindo S., Murota H., Seki T., Mori K., Kaizu K., Nishizaka T., Takagi Y., Katayama I. Effects of a moisturizer containing pseudo-ceramide and a eucalyptus extract on sweating function in adult atopic dermatitis: A double-blind, randomized, controlled left-right comparison clinical trial. J. Cosmet. Dermatol. 2022 doi: 10.1111/jocd.14923. - DOI - PubMed
    1. Bhat B.B., Kamath P.P., Chatterjee S., Bhattacherjee R., Nayak U.Y. Recent Updates on Nanocosmeceutical Skin Care and Anti-Aging Products. Curr. Pharm. Des. 2022 doi: 10.2174/1381612828666220321142140. - DOI - PubMed